Udara Dilrukshi Senarathne

Dr. Udara Dilrukshi Senarathne

Biochemistry, University of Sri Jayewardenepura, Colombo, Western, Sri Lanka
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Neluwa-Liyanage Ruwan IndikaNeluwa-Liyanage Ruwan Indika
Neluwa-Liyanage Ruwan Indika
RFRichard Frye
Richard Frye
Dan RossignolDan Rossignol
Dan Rossignol
SOSusan C. Owens
Susan C. Owens
Udara Dilrukshi SenarathneUdara Dilrukshi Senarathne
Udara Dilrukshi Senarathne
NDNicolaas E. P. Deutz
Nicolaas E. P. Deutz
Children with autism spectrum disorder may exhibit nutritional deficiencies due to reduced intake, genetic variants, autoantibodies interfering with vitamin transport, and the accumulation of toxic compounds that consume vitamins. Importantly, vitamins and metal ions are essential for several metabolic pathways and for neurotransmitter functioning. The therapeutic benefits of supplementing vitamins, minerals (Zinc, Magnesium, Molybdenum, and Selenium), and other cofactors (coenzyme Q10, alpha-lipoic acid, and tetrahydrobiopterin) are mediated through their cofactor as well as non-cofactor functions. Interestingly, some vitamins can be safely administered at levels far above the dose typically used to correct the deficiency and exert effects beyond their functional role as enzyme cofactors. Moreover, the interrelationships between these nutrients can be leveraged to obtain synergistic effects using combinations. The present review discusses the current evidence for using vitamins, minerals, and cofactors in autism spectrum disorder, the rationale behind their use, and the prospects for future use.

27 March 2023 in Genes
Verified
Journal Article
Open access
PDF file
Udara Dilrukshi SenarathneUdara Dilrukshi Senarathne
Udara Dilrukshi Senarathne
Neluwa-Liyanage Ruwan IndikaNeluwa-Liyanage Ruwan Indika
Neluwa-Liyanage Ruwan Indika
AJAleksandra Jezela-Stanek
Aleksandra Jezela-Stanek
ECElżbieta Ciara
Elżbieta Ciara
RFRichard Frye
Richard Frye
KSKarolina M Stepien
Karolina M Stepien
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders characterized by impaired social interaction, limited communication skills, and restrictive and repetitive behaviours. The pathophysiology of ASD is multifactorial and includes genetic, epigenetic, and environmental factors, whereas a causal relationship has been described between ASD and inherited metabolic disorders (IMDs). This review describes biochemical, genetic, and clinical approaches to investigating IMDs associated with ASD. The biochemical work-up includes body fluid analysis to confirm general metabolic and/or lysosomal storage diseases, while the advances and applications of genomic testing technology would assist with identifying molecular defects. An IMD is considered likely underlying pathophysiology in ASD patients with suggestive clinical symptoms and multiorgan involvement, of which early recognition and treatment increase their likelihood of achieving optimal care and a better quality of life.

1 October 2014 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
PEP.A.S. Edirisinghe
P.A.S. Edirisinghe
IKI.D.G. Kitulwatte
I.D.G. Kitulwatte
Udara Dilrukshi SenarathneUdara Dilrukshi Senarathne
Udara Dilrukshi Senarathne

23 October 2013 in International Journal of Injury Control and Safety Promotion
Verified
Journal Article
Closed access
AEAnuruddhi Samanthika Edirisinghe
Anuruddhi Samanthika Edirisinghe
IKIndira Deepthi Kitulwatte
Indira Deepthi Kitulwatte
Udara Dilrukshi SenarathneUdara Dilrukshi Senarathne
Udara Dilrukshi Senarathne
Reckless driving behaviour associated with alcohol has been well known. In Sri Lanka, research on blood alcohol concentration (BAC) in road fatalities is scares. Thus, we studied the BAC in vulnerable road users (VRUs) encountered in medico-legal autopsies. A retrospective descriptive study based on case records of VRU fatalities from 2005 to 2012 referred for a tertiary care unit for post-mortem examination was conducted. A pro-forma was developed to extract data from the post-mortem blood alcohol reports. Data were analysed using percentages and p-values. There were 119 cases from the 328 autopsies to investigate blood alcohol tests. A total of 51% (n = 61) out of 119 had BAC above 80 mg/100 ml and mean level was 103 mg/100 ml. 2/3 of pedestrians had a BAC above 80 mg/100 ml with a mean level of 139 mg/dl. The highest mean blood alcohol (158 mg/dl) was reported from three-wheeler users. Majority of cases with more than 80 mg/100 ml BAC was reported in the age group of 40–60 years, while 40% of the elderly too had a BAC above 80 mg/100 ml. The comparison between pedestrians having above 80 mg/100 ml of BAC with that of other VRUs (active road users) showed a significant statistical difference (p = 0.017). The study results suggest that alcohol influence among pedestrians represent a significant risk factor for fatal road traffic accidents.

30 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
EUElena Urizar
Elena Urizar
EMEamon McCarron
Eamon McCarron
Chaitanya GadepalliChaitanya Gadepalli
Chaitanya Gadepalli
ABAndrew Mark Bentley
Andrew Mark Bentley
PWPeter Woolfson
Peter Woolfson
KSKarolina M Stepien
Karolina M Stepien
Background: Lysosomal storage diseases (LSDs) are a genetically and clinically heterogeneous group of inborn errors of metabolism caused by variants in genes encoding lysosomal hydrolases, membrane proteins, activator proteins, or transporters. These disease-causing variants lead to enzymatic deficiencies and the progressive accumulation of undegraded substrates within lysosomes, disrupting cellular function across multiple organ systems. While classical phenotypes typically manifest in infancy or early childhood with severe multisystem involvement, a combination of advances in molecular diagnostics [particularly next-generation sequencing (NGS)] and improved understanding of disease heterogeneity have enabled the identification of attenuated forms characterised by residual enzyme activity and later-onset presentations. These milder phenotypes often evade early recognition due to nonspecific or isolated symptoms, resulting in significant diagnostic delays and missed therapeutic opportunities. Objectives/Methods: This study characterises the clinical, biochemical, and molecular profiles of 10 adult patients diagnosed with LSDs, all representing attenuated forms, and discusses them alongside a narrative review. Results: Enzyme activity, molecular data, and phenotypic assessments are described to explore genotype–phenotype correlations and identify diagnostic challenges. Conclusions: These findings highlight the variable expressivity and organ involvement of attenuated LSDs and reinforce the importance of maintaining clinical suspicion in adults presenting with unexplained cardiovascular, neurological, ophthalmological, or musculoskeletal findings. Enhanced recognition of atypical presentations is critical to facilitate earlier diagnosis, guide management, and enable cascade testing for at-risk family members.

29 September 2021 in BMJ Case Reports
Verified
Journal Article
Open access
PDF file
Udara Dilrukshi SenarathneUdara Dilrukshi Senarathne
Udara Dilrukshi Senarathne
RRRanmali Rodrigo
Ranmali Rodrigo
BDBolonghoge Krishantha Trixy Priyankara Dayanath
Bolonghoge Krishantha Trixy Priyankara Dayanath
Neonatal chylothorax is a rare presentation leading to significant respiratory distress, thus requiring timely diagnosis. A preterm neonate was resuscitated and ventilated, following which she clinically improved but subsequently developed respiratory distress with a right-sided pleural effusion. Interestingly, thoracentesis fluid appeared ‘milky’ with elevated triglycerides and lymphocytes, suggesting chylothorax. As fluid triglyceride level was lower than the established diagnostic criterion for chylothorax (1.24 mmol/L), a high fluid-to-serum triglyceride ratio was used as a surrogate diagnostic marker, later confirmed by lipoprotein electrophoresis. As observed in the index patient, a critically ill neonate would have a lower-than-average fat intake leading to less chylomicron production, thus lower triglyceride levels in chyle than expected, which may still fail to meet the amended cut-off limit. This case highlights the challenges in diagnosing neonatal chylothorax due to the lack of age-specific triglyceride levels in chyle and low oral fat intake in critically ill patients.